Ironwood Pharmaceuticals, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2017 | $-27.8M | $-28.9M | $1.0M | $7.3M |
| Jun 2017 | $-32.5M | $-33.2M | $709.0K | $9.1M |
| Sep 2017 | $-31.2M | $-32.7M | $1.5M | $8.7M |
| Dec 2017 | $-9.2M | $-8.8M | $-406.0K | $5.8M |
| Mar 2018 | $-30.9M | $-32.4M | $1.5M | $9.0M |
| Jun 2018 | $-22.7M | $-22.6M | $-62.0K | $9.0M |
| Sep 2018 | $-26.6M | $-25.2M | $-1.4M | $12.1M |
| Dec 2018 | $9.3M | $9.0M | $254.0K | $10.4M |
| Mar 2019 | $-42.4M | $-45.6M | $3.2M | $13.9M |
| Jun 2019 | $-9.2M | $-7.4M | $-1.8M | $6.3M |
| Sep 2019 | $34.8M | $31.7M | $3.1M | $5.5M |
| Dec 2019 | $27.6M | $24.9M | $2.7M | $5.5M |
| Mar 2020 | $43.6M | $42.2M | $1.4M | $6.4M |
| Jun 2020 | $20.1M | $19.7M | $376.0K | $7.1M |
| Sep 2020 | $53.6M | $53.6M | $0 | $7.7M |
| Dec 2020 | $51.5M | $51.5M | $28.0K | $10.0M |
| Mar 2021 | $73.7M | $73.7M | — | $5.4M |
| Jun 2021 | $48.6M | $48.6M | — | $4.6M |
| Sep 2021 | $75.1M | $75.1M | — | $6.2M |
| Dec 2021 | $64.6M | $64.6M | — | $6.1M |
| Mar 2022 | $64.1M | $64.1M | $9.0K | $6.1M |
| Jun 2022 | $61.4M | $61.3M | $88.0K | $6.6M |
| Sep 2022 | $69.1M | $69.0M | $66.0K | $7.1M |
| Dec 2022 | $79.2M | $79.2M | $-27.0K | $7.3M |
| Mar 2023 | $80.2M | $80.2M | $13.0K | $7.1M |
| Jun 2023 | $35.0M | $35.0M | $0 | $8.3M |
| Sep 2023 | $32.5M | $32.4M | $49.0K | $7.9M |
| Dec 2023 | $35.8M | $35.6M | $211.0K | $8.7M |
| Mar 2024 | $45.0M | $44.9M | $68.0K | $8.4M |
| Jun 2024 | $33.5M | $33.4M | $58.0K | $8.6M |
| Sep 2024 | $9.9M | $9.9M | $16.0K | $8.3M |
| Dec 2024 | $15.2M | $15.2M | $0 | $4.6M |
| Mar 2025 | $20.0M | $19.9M | $31.0K | $5.3M |
| Jun 2025 | $-15.1M | $-15.1M | $2.0K | $4.5M |
| Sep 2025 | $47.6M | $47.6M | $2.0K | $3.6M |
| Dec 2025 | $74.6M | $74.6M | $-1.0K | $3.8M |
| Mar 2026 | $5.1M | $5.1M | — | $3.7M |
| Jun 2026 | $58.3M | $58.3M | — | $3.2M |